Copyright © 2000 by the European Society of Cardiology.
Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study
a Wolfson Unit for Prevention of Peripheral Vascular Diseases, Public Health Sciences, University of Edinburgh Medical School, U.K.
b Haemostasis Thrombosis and Vascular Medicine Unit, University Department of Medicine, Glasgow Royal Infirmary, U.K.
revised January 14, 2000; accepted January 19, 2000
Abstract
Aims To evaluate the relationship between haemostatic and rheological factors and cardiovascular outcome in subjects with angina pectoris in the general population.
Methods and Results Two hundred and seven men and women aged 5574 had evidence of angina at baseline. Sixty-seven (32·3%) had a fatal or non-fatal cardiovascular event during follow-up. Median levels of tissue plasminogen activator antigen and leucocyte elastase were higher in the event group compared with the no event group (10·0ng.ml1vs 7·2ng.ml1;P
0·001, and 40·3ng.ml1vs 31·0ng.ml1;P
0·01, respectively). Whole blood viscosity was also significantly higher in the event group than in the no event group (3·80mPa.s vs 3·53mPa.s;P
0·05). After adjusting for age and sex, unit increases in both tissue plasminogen activator antigen and leucocyte elastase levels were significantly associated with an increased risk of a cardiovascular event. These associations remained after further adjusting for cardiovascular risk factors and baseline myocardial infarction. The relative risks were 2·07 (95% CI, 1·303·45;P
0·01) for tissue plasminogen activator antigen and 1·95 (95% CI, 1·123·50;P
0·05) for leucocyte elastase.
Conclusion Disturbed fibrinolysis and activation of leucocytes may be implicated in the development of thrombotic cardiovascular events in subjects with angina pectoris in the general population.
Key Words: Angina pectoris, cardiovascular events, tissue plasminogen activator, leucocyte elastase
f1 Correspondence: Dr Felicity Smith, Wolfson Unit for Prevention of Peripheral Vascular Diseases, Public Health Sciences, University of Edinburgh, Medical School, Teviot Place, Edinburgh EH8 9AG, U.K.
References
- Falk E, Fuster V. Angina pectoris and disease progression. Circulation. 1995;92:20332035
[Free Full Text] - Thompsom SG, Fechtrup C, Squire E. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris. Arterioscler Thromb Vasc Biol. 1996;16:357362
[Abstract/Free Full Text] - Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635641
[Abstract/Free Full Text] - Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation. 1997;96:42044210
[Abstract/Free Full Text] - Benderly M, Graff E, Reicher-Reiss H, Behar S, Brunner D, Goldbourt U. Fibrinogen is a predictor of mortality in coronary heart disease patients. Arterioscler Thromb Vasc Biol. 1996;16:351356
[Abstract/Free Full Text] - Jansson JH, Olofsson B-O, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up. Circulation. 1993;88:20302034
[Abstract/Free Full Text] - Held C, Hjemdahl P, Rehnqvist N. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm. Circulation. 1997;95:20302038
- Jansson JH, Nilsson TK, Olofsson BO. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris. Eur Heart J. 1991;12:157161
[Abstract/Free Full Text] - Juhan-Vague I, Pyke SDM, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 1996;94:20572063
[Abstract/Free Full Text] - Neumann F-J, Katus HA, Hoberg E. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J. 1991;66:425460
[Abstract/Free Full Text] - Fuchs J, Pinhas E, Davidson E, Rotenberg Z, Agmon J, Weinberger I. Plasma viscosity, fibrinogen and haematocrit in the course of unstable angina. Eur Heart J. 1990;11:10291032
[Abstract/Free Full Text] - Fowkes FGR, Housley E, Cawood EHH, MacIntyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:382392
- Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Boston: John Wright PSG, Inc; 1982.
- Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Org. 1962;27:645658[ISI][Medline]
- Lowe GDO, Wood DA, Douglas JT. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost. 1991;65:339343[ISI][Medline]
- Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989;96:978982[ISI][Medline]
- Gillum RF, Fortmann SP, Prinease RJ, Korrke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984;108:150158[CrossRef][ISI][Medline]
- Leng GC, Lee AJ, Fowkes FGR. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25:11721181
[Abstract/Free Full Text] - Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:15951607[Abstract]
- Henderson A. Coronary heart disease: overview. Lancet. 1996;348:S1S4
- Wolin MS, Rodenberg JM, Messina EJ, Kaley G. Oxygen metabolites and vasomotor mechanisms in rat cremasteric arterioles. Am J Physiol. 1987;252:H-1159H-1163
- Lowe GDO. Blood rheology and arterial disease. Clin Sci. 1986;71:137146[Medline]
- Marcus AJ. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism. Blood. 1990;76:19031907
[Free Full Text] - Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775778
[Abstract/Free Full Text] - Moreno PR, Bernardi VH, Lopez-Cuellar J. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation. 1996;94:30903097
[Abstract/Free Full Text] - Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation. 1993;87:19151920
[Abstract/Free Full Text] - Leng GC, Lee AJ, Fowkes FGR. Randomized controlled trial of antioxidants in intermittent claudication. Vasc Med. 1997;2:279285[Medline]
- Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med. 1987;317:13611365[Abstract]
- Becker RC, Cannon CP, Bovill EG. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI III Trial). Am J Cardiol. 1996;78:142147[ISI][Medline]
- Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol. 1998;18:13591362
[Free Full Text] - Rainer C, Kawanishi DT, Chandraratna PAN. Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease. Circulation. 1987;76:1520
[Abstract/Free Full Text] - Neumann F-J, Tillmans H, Roebruck P, Zimmerman R, Haupt H-M, Kubler W. Haemorrheological abnormalities in unstable angina pectoris: a relation independent of risk factor profile and angiographic severity. Br Heart J. 1989;62:421428
[Abstract/Free Full Text] - Neumann F-J, Katus HA, Roebruck P. Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J. 1991;66:425430
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
H. Hemingway, C. Langenberg, J. Damant, C. Frost, K. Pyorala, and E. Barrett-Connor Prevalence of Angina in Women Versus Men: A Systematic Review and Meta-Analysis of International Variations Across 31 Countries Circulation, March 25, 2008; 117(12): 1526 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lo Presti, M. Montana, G. Amodeo, E. Incalcaterra, and G. Caimi Persistence of High Plasma Elastase Level in Young Subjects With Acute Myocardial Infarction Clinical and Applied Thrombosis/Hemostasis, April 1, 2007; 13(2): 224 - 225. [PDF] |
||||
![]() |
G.D.O. Lowe, J. Danesh, S. Lewington, M. Walker, L. Lennon, A. Thomson, A. Rumley, and P.H. Whincup Tissue plasminogen activator antigen and coronary heart disease: Prospective study and meta-analysis Eur. Heart J., February 1, 2004; 25(3): 252 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fernandez, P. Marco, F. Marin, V. Roldan, and F. Sogorb The role of tissue plasminogen activator on the progression of the coronary disease Eur. Heart J., January 1, 2002; 23(1): 88 - 88. [Full Text] [PDF] |
||||
![]() |
P.J. Grant The Edinburgh Artery Study: is lytic activity bad for the heart? Eur. Heart J., October 1, 2000; 21(19): 1566 - 1567. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



